Navigation Links
BRISTOL-MYERS SQUIBB SELECTS ISIS DRUG TARGETING PCSK9 AS DEVELOPMENT CANDIDATE FOR PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE
Date:4/8/2008

Isis To Receive $2 Million Milestone Payment

CARLSBAD, Calif., April 8, 2008 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Bristol-Myers Squibb Company (NYSE: BMY) has selected a compound from the companies' collaboration as a development candidate. As a result, Isis will receive a $2 million milestone payment. The two companies have an ongoing collaboration to identify antisense drugs that target proprotein convertase subtilisin kexin 9 (PCSK9). The development candidate is an antisense inhibitor of PCSK9 that helps regulate the amount of cholesterol in the bloodstream.

The selection of this development candidate marks the achievement of the first milestone in this collaboration, which was announced on May 9, 2007. The compound was designed to selectively inhibit the production of PCSK9 and could offer a new and complementary mechanism to current lipid-lowering therapies for the prevention and treatment of cardiovascular disease.

"In less than a year, we have been able to identify and characterize a number of antisense drugs that inhibit PCSK9 in pre-clinical studies and out of those, identified an attractive development candidate. With the selection by Bristol-Myers Squibb of this development candidate, we have achieved our first milestone. The rapid progress we have made with our PCSK9 program is representative of the efficiency of our antisense technology to quickly move from target to drug," said Brett Monia, Ph.D., Vice President of Antis
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
2. Bristol-Myers Squibb to Acquire Adnexus Therapeutics
3. Aureus Pharma Announces Renewal and Expansion of Licensing Agreement With Bristol-Myers Squibb for its AurSCOPE Knowledge Databases
4. Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
5. Bristol-Myers Squibb Company Outlines Strategy and Productivity Transformation Initiative During Update to Investment Community
6. EDS Awarded $715 Million Contract for Bristol-Myers Squibb Information Services
7. Exelixis Submits XL139 Diligence Report to Bristol-Myers Squibb
8. Bristol-Myers Squibb to Announce Results for the Fourth Quarter and Full Year of 2007 on January 31
9. Bristol-Myers Squibb Board Elects James M. Cornelius Chairman of the Board
10. Bristol-Myers Squibb Announces Dividend
11. Bristol-Myers Squibb Board Elects Jean-Marc Huet Senior Vice President and Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's new $100,000 waste ... energy process and continue to contribute to the sustainability of our natural resources. ... Energy process has been operating at their Mexico facility, Recicladora Temarry, for the ...
(Date:9/2/2015)... ... 2015 , ... Genedata, a leading provider of advanced software ... ® version 13.0 at ELRIG Drug Discovery 2015. This latest version of the ... new capabilities. Screener now supports High Throughput Flow Cytometry (HT-Flow) and Drug Metabolism ...
(Date:9/1/2015)... ... September 02, 2015 , ... Spirax Sarco , the leader in products ... Spirax Sarco Anytime. This platform, offering unique online ordering capabilities, is only available ... Log on to Spirax Sarco Anytime and within minutes you can be making ...
(Date:9/1/2015)... , Sept. 1, 2015  ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... 17 th Annual Global Investment Conference sponsored by ... 8-10, 2015 at The St. Regis Hotel in ... James Sapirstein , Chief Executive Officer, will provide ...
Breaking Biology Technology:Temarry Recycling’s New $100,000 Waste to Energy Renovation 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 2New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 3New Genedata Screener 13.0 with Support for High Throughput Flow Cytometry and DMPK Unveiled at ELRIG 4Spirax Sarco Announces New Features to Anytime Platform 2ContraVir to Present at Rodman & Renshaw 17th Annual Global Investment Conference 2
... (Nasdaq: MSHL ) will present at the BIO ... Thursday, October 11, 2007 at 12:00 pm. About ... MSHL ) is a specialist oncology company,focused on the ... flavonoid technology platform which has generated a,number of novel ...
... PRXL ) will release First Quarter Fiscal Year ... close of the,stock market. The announcement will be available ... PR Newswire website at http://www.prnewswire.com . PAREXEL ... 10:00 a.m. ET,on Thursday, October 25, 2007 to discuss ...
... more than 70 million,Generation Y employees starting to ... workplace, smart companies are paying,attention, providing these future ... wants and needs. (Photo: http://www.newscom.com/cgi-bin/prnh/20071003/AQW903 ) ... the global health care company,Abbott, which was recently ...
Cached Biology Technology:Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 3PAREXEL Announces Date of First Quarter Fiscal Year 2008 Earnings Release and Conference Call 2Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek 2Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek 3Abbott Named One of the 'Best Places to Launch a Career' by BusinessWeek 4
(Date:8/10/2015)... and TELTOW, Germany , ... Instruments (SMI), a world leader in Eye Tracking ... completion of its OEM Eye Tracking Platform for integration ... Tracking Platform contains reference designs for seamless integration of ... systems, virtual reality HMDs and augmented reality smart glasses. ...
(Date:8/6/2015)... CITY, Calif. , Aug. 6, 2015 /PRNewswire/ ... Valley) will visit Crossmatch ™ to learn ... networks and protect data. Crossmatch is a world ... whose technologies and expertise are helping federal agencies ... efficiency and security.   "The vast ...
(Date:8/6/2015)... SAN JOSE, Calif. , Aug. 6, 2015 ... the leading developer of human interface solutions, today ... and TouchPad technologies on Windows 10. Microsoft leveraged ... fundamental to the operating system. ... and drivers are fully certified with Microsoft,s Precision ...
Breaking Biology News(10 mins):SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 2SMI Completes OEM Eye Tracking Platform to Cover All Consumer Displays 3Rep. Honda to Visit Crossmatch in Redwood City 2Synaptics Chosen for Human Interface Co-Development on Windows 10 2
... bacteria using electricity instead of iron, an advance that will ... day be used to turn electricity into fuel. The study ... the online open-access journal of the American Society for Microbiology. ... with a steady supply of electrons that the bacteria use ...
... NY, January 28, 2013The U.S. Department of Agriculture (USDA) ... 250 nanoscale science and engineering projects that could lead ... of current projects in development are presented in a ... a peer-reviewed journal from Mary Ann Liebert Inc., ...
... (January 28, 2013) The Damon Runyon Cancer ... innovative early career researchers, named 15 new Damon ... review. The recipients of this prestigious, three-year ... translational cancer research in the laboratories of leading ...
Cached Biology News:Scientists trick iron-eating bacteria into breathing electrons instead 2Innovative uses of nanotechnology in food and agriculture 2Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists 2Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists 3Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists 4Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists 5Damon Runyon Cancer Research Foundation grants prestigious awards to 17 young scientists 6
... Transporter 2 (VMAT2). An antibody made to ... band at ~55 kDa in postnuclear supernatants ... in wild type cells (2). Some additional ... were also detected and remain unaffected by ...
... Gel Loading Buffer contains a precipitant to ensure ... a tracking dye to allow the user to ... ReddyRun™: ABgene ® s proprietary ... the same buffer composition used in ReddyRun™ molecular ...
... Insulin exerts its effects ... insulin receptor, a disulfide-linked ... two Alpha subunits and ... in the following configuration: ...
... loading buffer is especially formulated for non-denaturing ... acids. The gel loading solution contains a ... add density and facilitate sample loading. EDTA ... require divalent cations and SDS has been ...
Biology Products: